Indresh Srivastava

Publication List Details

Period

2005 - 2005

Number

9

Co-Authors

Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins

Otten, Gillis R., Schaefer, Mary, Doe, Barbara, Liu, Hong, Srivastava, Indresh, Zur Megede, Jan, ...

DNA vaccines have been used widely in experimental primate models of human immunodeficiency virus (HIV), but their effectiveness has been limited. In this study, we evaluated three technologies for...

Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies

Peng, Bo, Wang, Liqun Rejean, Gómez-Román, Victor Raúl, Davis-Warren, Alberta, Montefiori, David C., Kalyanaraman, V. S., ...

A major challenge in combating the human immunodeficiency virus (HIV) epidemic is the development of vaccines capable of inducing potent, persistent cellular immunity and broadly reactive...

Evaluation of Envelope Vaccines Derived from the South African Subtype C Human Immunodeficiency Virus Type 1 TV1 Strain

Lian, Ying, Srivastava, Indresh, Gómez-Román, V. Rául, Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...

Human immunodeficiency virus type 1 (HIV-1) subtype C infections are on the rise in Sub-Saharan Africa and Asia. Therefore, there is a need to develop an HIV vaccine capable of eliciting broadly...

Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins

Otten, Gillis R., Schaefer, Mary, Doe, Barbara, Liu, Hong, Srivastava, Indresh, Zur Megede, Jan, ...

DNA vaccines have been used widely in experimental primate models of human immunodeficiency virus (HIV), but their effectiveness has been limited. In this study, we evaluated three technologies for...

Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies

Peng, Bo, Wang, Liqun Rejean, Gómez-Román, Victor Raúl, Davis-Warren, Alberta, Montefiori, David C., Kalyanaraman, V. S., ...

A major challenge in combating the human immunodeficiency virus (HIV) epidemic is the development of vaccines capable of inducing potent, persistent cellular immunity and broadly reactive...

Evaluation of Envelope Vaccines Derived from the South African Subtype C Human Immunodeficiency Virus Type 1 TV1 Strain

Lian, Ying, Srivastava, Indresh, Gómez-Román, V. Rául, Zur Megede, Jan, Sun, Yide, Kan, Elaine, ...

Human immunodeficiency virus type 1 (HIV-1) subtype C infections are on the rise in Sub-Saharan Africa and Asia. Therefore, there is a need to develop an HIV vaccine capable of eliciting broadly...